BVSBioventus Inc.

$593M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$130M+32.3% YoY

Gross Profit

$88M67.3% margin

Operating Income

-$3M-2.4% margin

Net Income

-$364,000-0.3% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+19.8%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$692M

Stockholders' Equity

$459M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$130M	$99M	+32.3%
Gross Profit	$88M	$73M	+19.5%
Operating Income	-$3M	$6M	-153.3%
Net Income	-$364,000	$3M	-113.1%

Revenue Segments

Restorative Therapies

$37M100%

Geographic Segments

UNITED STATES

$115M88%

Non-US

$15M12%

BVS Q4 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena